Single-nucleotide polymorphisms in the promoter of the CDK5 gene and lung cancer risk in a Korean population

Journal of Human Genetics

Volumn 54, Issue 5, 2009, Pages 298-303

  Choi, Hyo Seon ^a   Lee, Youngin ^b   Park, Kyong Hwa ^a   Sung, Jae Sook ^a,c   Lee, Jong Eun ^d   Shin, Eun Soon ^d   Ryu, Jeong Seon ^e   Kim, Yeul Hong ^a,c  

^a College of Medicine   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Korea University   (South Korea)

^d DNA Link Inc   (South Korea)

^e Inha University School of Medicine   (South Korea)

Author keywords

Cyclin dependent kinase 5 (CDK5); Lung cancer; Single nucleotide polymorphism

Indexed keywords

CYCLIN DEPENDENT KINASE 5;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; CYCLIN-DEPENDENT KINASE 5; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REPUBLIC OF KOREA; SMOKING;

EID: 67649566961     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2009.29     Document Type: Article

References (27)

1. Lew, J., Beaudette, K., Litwin, C. M. & Wang, J. H. Purification and characterization of a novel proline-directed protein kinase from bovine brain. J. Biol. Chem. 267, 13383-13390 (1992a).
2. Lew, J., Winkfein, R. J., Paudel, H. K. & Wang, J. H. Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. J. Biol. Chem. 267, 25922-25926 (1992b).
3. Chen, F. & Studzinski, G. P. Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. Blood 97, 3763-3767 (2001).
4. Tsai, L. H., Takahashi, T., Caviness, V. S. Jr. & Harlow, E. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119, 1029-1040 (1993).
5. Chen, F. & Studzinski, G. P. Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells. Exp. Cell Res. 249, 422-428 (1999).
6. Chen, F., Wang, Q., Wang, X. & Studzinski, G. P. Up-regulation of Egr1 by 1,25-dihydroxyvitamin D3 contributes to increased expression of p35 activator of cyclin-dependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation. Cancer Res. 64, 5425-5433 (2004).
7. Gao, C. Y., Rampalli, A. M., Cai, H. C., He, H. Y. & Zelenka, P. S. Changes in cyclin dependent kinase expression and activity accompanying lens fiber cell differentiation. Exp. Eye Res. 69, 695-703 (1999).
8. Lazaro, J. B., Kitzmann, M., Poul, M. A., Vandromme, M., Lamb, N. J. & Fernandez, A. Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J. Cell Sci. 110 (Pt 10), 1251-1260 (1997).
9. Lilja, L., Yang, S. N., Webb, D. L., Juntti-Berggren, L., Berggren, P. O. & Bark, C. Cyclindependent kinase 5 promotes insulin exocytosis. J. Biol. Chem. 276, 34199-34205 (2001).
10. Session, D. R., Fautsch, M. P., Avula, R., Jones, W. R., Nehra, A. & Wieben, E. D. Cyclin-dependent kinase 5 is expressed in both Sertoli cells and metaphase spermatocytes. Fertil. Steril. 75, 669-673 (2001).
11. Studzinski, G. P. & Harrison, J. S. The neuronal cyclin-dependent kinase 5 activator p35Nck5a and Cdk5 activity in monocytic cells. Leuk. Lymphoma 44, 235-240 (2003).
12. Strock, C. J., Park, J. I., Nakakura, E. K., Bova, G. S., Isaacs, J. T., Ball, D. W. et al. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res. 66, 7509-7515 (2006).
13. Liu, R., Tian, B., Gearing, M., Hunter, S., Ye, K. & Mao, Z. Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proc. Natl Acad. Sci. USA 105, 7570-7575 (2008).
14. Lin, H., Chen, M. C., Chiu, C. Y., Song, Y. M. & Lin, S. Y. Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells. J. Biol. Chem. 282, 2776-2784 (2007).
15. Sandal, T., Stapnes, C., Kleivdal, H., Hedin, L. & Doskeland, S. O. A novel, extraneuronal role for cyclin-dependent protein kinase 5 (CDK5): modulation of cAMPinduced apoptosis in rat leukemia cells. J. Biol. Chem. 277, 20783-20793 (2002).
16. Fu, A. K., Fu, W. Y., Ng, A. K., Chien, W. W., Ng, Y. P., Wang, J. H. et al. Cyclindependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity. Proc. Natl Acad. Sci. USA 101, 6728-6733 (2004).
17. Lockwood, W. W., Chari, R., Coe, B. P., Girard, L., Macaulay, C., Lam, S. et al. DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers. Oncogene 27, 4615-4624 (2008).
18. Bogush, A., Pedrini, S., Pelta-Heller, J., Chan, T., Yang, Q., Mao, Z. et al. AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro. J. Biol. Chem. 282, 7352-7359 (2007).
19. Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N. et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22, 231-238 (1999).
20. Ramensky, V., Bork, P. & Sunyaev, S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30, 3894-3900 (2002).
21. Wang, D. G., Fan, J. B., Siao, C. J., Berno, A., Young, P., Sapolsky, R. et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280, 1077-1082 (1998).
22. Sung, J. S., Han, S. G., Whang, Y. M., Shin, E. S., Lee, J. W., Lee, H. J. et al. Putative association of the single nucleotide polymorphisms in RASSF1A promoter with Korean lung cancer. Lung Cancer 61, 301-308 (2008).
23. Liu, R., Tian, B., Gearing, M., Hunter, S., Ye, K. & Mao, Z. Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proc. Natl Acad. Sci. USA 105, 7570-7575 (2008).
24. Bader, J. S. The relative power of SNPs and haplotype as genetic markers for association tests. Pharmacogenomics 2, 11-24 (2001).
25. Choi, J. E., Park, S. H., Kim, K. M., Lee, W. K., Kam, S., Cha, S. I. et al. Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study. BMC Cancer 7, 199 (2007).
26. Judson, R. & Stephens, J. C. Notes from the SNP vs haplotype front. Pharmacogenomics 2, 7-10 (2001).
27. Judson, R., Stephens, J. C. & Windemuth, A. The predictive power of haplotypes in clinical response. Pharmacogenomics 1, 15-26 (2000).